Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study

Medical Oncology

Volumn 32, Issue 3, 2015, Pages

  Chakrabarti, Sanjukta ^a   Multani, Shaleen ^b   Dabholkar, Jyoti ^c   Saranath, Dhananjaya ^a,b  

^a RELIANCE LIFE SCIENCES PVT LTD   (India)

^b NMIMS UNIVERSITY   (India)

^c KEM HOSPITAL   (India)

Author keywords

Chewing tobacco habit; Gene expression profile; High throughput assay; Illumina microarray system; Indian patients; Oral cancer

Indexed keywords

B CELL ACTIVATING FACTOR; BIOLOGICAL MARKER; COMPLEMENTARY DNA; CXCL13 CHEMOKINE; OSTEOPONTIN; PROTEIN; PROTEIN ALDH3A1; PROTEIN AMI2; PROTEIN CD300A; PROTEIN CLEC4A; PROTEIN DAPL1; PROTEIN ELF5; PROTEIN EPHB6; PROTEIN FAP; PROTEIN FOLR2; PROTEIN GLIPR1; PROTEIN HTR3B; PROTEIN IFIT2; PROTEIN MME; PROTEIN NNMT; PROTEIN TMPRSS11A; PROTEIN TNFAIP6; PROTEIN TREM2; PROTEIN WISP1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; BIOLOGICAL FUNCTIONS; CELL DIFFERENTIATION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; METASTASIS; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; PILOT STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKELESS TOBACCO; UPREGULATION; XENOBIOTIC METABOLISM; ADVERSE EFFECTS; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; INDIA; MIDDLE AGED; MOUTH NEOPLASMS; REFERENCE VALUE;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; INDIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; REFERENCE VALUES; TOBACCO, SMOKELESS;

EID: 84922359863     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0483-4     Document Type: Article

References (42)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.
2. Bhatnagar R, Dabholkar J, Saranath D. Genome-wide disease association study in chewing tobacco associated oral cancers. Oral Oncol. 2013;48(9):831–5.
3. Subramanian SV, Nandy S, Kelly M, Gordon D, Smith GD. Patterns and distribution of tobacco consumption in India: cross sectional multilevel evidence from the 1998–9 national family health survey. BMJ. 2004;328:801.
4. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010;11(2):165–73.
5. Sasaki T, Moles DR, Imai Y, Speight PM. Clinico-pathological features of squamous cell carcinoma of the oral cavity in patients <40 years of age. J Oral Pathol Med. 2005;34(3):129–33.
6. Annertz K, Anderson H, Biörklund A, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer. 2002;10(1):95–9.
7. Kuriakose M, Sankaranarayanan M, Nair MK, et al. Comparison of oral squamous cell carcinoma in younger and older patients in India. Eur J Cancer B Oral Oncol. 1992;28(2):113–20.
8. Molinolo AA, Hewitt SM, Amornphimoltham P, et al. Dissecting the akt/mTOR signalling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res. 2007;13(17):4694–973.
9. Rai R, Kulkarni V, Saranath D. Genome wide instability scanning in chewing- tobacco associated oral cancer using inter-simple sequence repeat PCR. Oral Oncol. 2004;40(10):1033–9.
10. Rai R, Kulkarni V, Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol. 2003;40(2):145–53.
11. Saranath D. Integrated biology and molecular pathology of oral cancer. In: Contemporary Issues in Oral Cancer. Oxford; 2000.
12. Balmain A, Barrett JC, Moses H, Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog. 1993;7:139–46.
13. Saranath D, Bhoite L, Madhav G. Molecular lesions in human oral cancer: the Indian scene. Eur J Cancer B Oral Oncol. 1993;29(2):107–12.
14. McKay JD, Truong T, Gaborieau V, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet. 2011;7(3):e1001333.
15. Saintigny P, Zhang L, Fan YH, et al. Gene expression profiling predicts the development of oral cancer. Cancer Prev Res. 2011;4:218.
16. Estilo CL, Pornchai O, Talbot S, et al. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer. 2009;9:11.
17. Severino P, Alvares AM, Michaluart P, et al. Global gene expression profiling of oral cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes. 2008;1:113.
18. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res. 2002;62:1184–90.
19. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001;20(43):6196–204.
20. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. PNAS. 1998;95(25):14863–8.
21. Gene ontology consortium. http://www.geneontology.org/ Accessed 20 Nov 2014.
22. DAVID bioinformatics resources. http://david.abcc.ncifcrf.gov/ Accessed 20 Nov.
23. Kyoto encyclopedia of genes and genomes. http://www.genome.jp/kegg/ Accessed 20 Nov.
24. Genecards the human gene compendium. http://www.genecards.org/ Accessed 20 Nov.
25. National center for biotechnology information. http://www.ncbi.nlm.nih.gov/ Accessed 20 Nov.
26. Lai KC, Liu CJ, Chang KW, Lee TC. Enhanced expression of ASB6 and IFIT2 in oral squamous cell carcinoma. Proc Am Assoc Cancer Res. 2006;1:215.
27. Lai KC, Liu CJ, Chang KW, Lee TC. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells. Oncogene. 2013;32:3686–97.
28. Ribeiro L, De Cassia GA, Cunha Q, Leles R, Batista C. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastatis and local host defense. Oncol Rep. 2007;18:1107–13.
29. Worsham MJ, Stephen JK, Lu M, et al. Disparate molecular, histopathology, and clinical factors in HNSCC racial groups. Otolaryngol Head Neck Surg. 2011;145(2):64.
30. Wikberg ML, Edin S, Lundberg IV, et al. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumor Biol. 2013;34(2):1013–20.
31. Dihlmann S, Tao S, Echterdiek F, et al. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients. Int. J. Cancer. 2014;135(10):2387–96.
32. Patsos G, Germann A, Gebert J, Dihlmann S. Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells. Int J Cancer. 2010;126(8):1838–49.
33. Jia J, Martin TA, Ye L, Jiang WG. FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biol. 2014;15:16.
34. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mänsson H. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomark Prev. 2007;16(6):1087–97.
35. Kretschmer C, Sterner-Kock A, Siedentopf F, Schoenegg W, Schlag PM, Kemmner W. Identification of early molecular markers for breast cancer. Mol Cancer. 2011;10(1):15.
36. Zhang H, Liu HB, Yuan DM, Wang ZF, Wang YF, Song Y. Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer. BMC Cancer. 2014;14(1):280.
37. Tang SW, Yang TC, Lin WC, Chang WH, Wang CC, Lai MK, Lin JY. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis. 2011;32(2):138–45.
38. Ruano Y, Mollejo M, Ribalta T, et al. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol cancer. 2006;5(1):39.
39. Kashyap MK, Marimuthu A, Kishore CJ, et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther. 2009;8(1):1–11.
40. Botton T, Puissant A, Cheli Y. Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth. Cell Death Differ. 2011;18(1):109–21.
41. Sabatier R, Finetti P, Adelaide J, et al. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One. 2011;6(11):e27656.
42. Yu J, Bulk E, Ji P. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non–small cell lung cancer. Clin Cancer Res. 2010;16(8):2275–83.